slides · global inventory
27 Cost Of Inaction
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 31,900
Current window 18,061-18,090
Pages 1,064
Rows per page 30
Loop
18,061-18,090 of 31,900
11
The slide uses a bar chart for historical growth and a pie chart for current composition.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses annotations to explicitly call out the 'funding advantage' in basis points (bps) at two specific time points.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide uses a clear 'past vs. future' structure to demonstrate operational discipline.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a consistent color scheme where teal represents the company and pink represents the peer group.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Includes dividend history, share repurchases, and regulatory capital cushion.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a three-column layout to show the individual strengths of the partners and the synergy of the combined therapy.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide outlines a clinical trial protocol using a sequential phase design.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide features a person sitting on a rock overlooking a landscape, with the company logo on their jacket.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide provides a scientific foundation for the CLDN6xCD3 bispecific antibody program.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide highlights CLDN6 in the context of the CLDN family tree.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a list-based structure to present three key pillars of the target's clinical profile.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The table highlights the prevalence column with an orange box.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide illustrates the modular assembly of a bispecific antibody from two distinct components.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The charts show dose-response curves where the proprietary antibodies (IM301, IM302) maintain high binding to CLDN6 while showing minimal off-target binding compared to the benchmark.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide compares the library against a benchmark (IMAB027) in terms of reactivity and cytotoxicity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide features a person sitting on a mountain peak, which is a common visual metaphor for vision or future outlook.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses a timeline format to track progress of two distinct drug development programs.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
24
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectively, creating a market need.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
06
The slide uses a biological pathway diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The chart uses a standard waterfall bridge to explain the variance in EBITDA between two periods.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
13
The chart uses a waterfall bridge to explain the movement of cash over a 12-month period.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
09
The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
Includes scientific citation at the bottom.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide uses a visual process flow to explain the mechanism of action.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit